Specialty Focus Dow Pharmaceutical Sciences specializes in semi-solid and liquid formulations, offering deep expertise and a track record of stabilizing and scaling such products, which presents a targeted opportunity to win partnerships from clients needing niche formulation support.

Regulatory Expertise Strong regulatory experience with multiple NDAs, numerous INDs, and frequent FDA interactions suggests Dow can accelerate product approvals for clients, making the firm appealing to sponsors seeking efficient regulatory pathways.

Clinical & Nonclinical Experience spanning nonclinical and clinical considerations enables end-to-end development support, appealing to clients needing integrated CMC, toxicology, and clinical strategy alongside formulation work.

Recent Track Record A history of assisting over 75 clients in the past three years with stable, scalable, disease-compatible formulations indicates reliability and capability to handle diverse programs, which can be pitched to risk-averse sponsors.

SME Alignment Smaller to mid-size client focus (51-200 employees) positions Dow as a nimble, dedicated partner for pharmaceutical sponsors seeking specialized, hands-on expertise without the scale of larger CROs.